Proliferative intercellular signalling pathway in human malignant mesothelioma cells

J. Zhong, M. Tamm, D. Lardinois, M. Roth (Switzerland)

Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Session: Basic mechanisms in malignant pleural disease biology
Session type: Oral Presentation
Number: 3858
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Zhong, M. Tamm, D. Lardinois, M. Roth (Switzerland). Proliferative intercellular signalling pathway in human malignant mesothelioma cells. Eur Respir J 2010; 36: Suppl. 54, 3858

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Species specific intercellular signalling pathway in human and rat mesothelioma cells
Source: Annual Congress 2009 - New insights in biology and treatment of pleural tumours
Year: 2009



LSC - 2017 - Targeting CD98hc: a key mediator of tumour and microenvironmental crosstalk in malignant mesothelioma
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Dissecting the mTOR pathway in malignant pleural mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



Hypertonicity increases apparent water permeability in benign mesothelial cells but differentially regulates it in epithelioid mesothelioma cells depending on the osmotic agent
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007



Effects of mTOR Inhibition in malignant mesothelioma
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010

Leptin activates the JAK/STAT signaling pathway in bronchial and alveolar epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 338s
Year: 2006

LSC 2010 Abstract: Macrophages promote proliferation of lung cancer cell by activation of NF-κB
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010


Altered pathways from alveolar epithelial cells
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016

All-trans-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



The regulatory effect of microRNAs on STAT signaling in malignant mesothelioma
Source: Annual Congress 2011 - Treatment options and tumour biology of malignant pleural mesothelioma
Year: 2011


Osteopontin of either host or tumor origin critically affects malignant pleural effusion formation
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010

WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Late Breaking Abstract - WNT/ß-catenin signaling induces cellular senescence in lung alveolar epithelial cells
Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease
Year: 2019

Effects of Cisplatin and Pemetrexed on the cell viability and cell adhesion of benign mesothelial and mesothelioma cells.
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

CXCL12 expression in malignant mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 138s
Year: 2007

Late Breaking Abstract - Membrane bile acid receptor contributes to the proliferation of lung cancer cells induced by lung fibroblast-tumor cells  interaction though TLR4/NF-kB signaling pathway
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Mesothelioma cells need mesothelial cell derived MT1-MMP to activate pro-MMP-2 and migration
Source: Eur Respir J 2005; 26: Suppl. 49, 553s
Year: 2005